Gujarat Pipavav Port Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 8:38 am

Competitors of Gujarat Pipavav Port Ltd

All Competitor Stocks of Gujarat Pipavav Port Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:55 am

Below is a detailed analysis of the quarterly data for Gujarat Pipavav Port Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 250.00 Cr.. The value appears to be declining and may need further review. It has decreased from 252.00 Cr. (Mar 2025) to 250.00 Cr., marking a decrease of 2.00 Cr..
• For Expenses, as of Jun 2025, the value is 102.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 95.00 Cr. (Mar 2025) to 102.00 Cr., marking an increase of 7.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 148.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Mar 2025) to 148.00 Cr., marking a decrease of 9.00 Cr..
• For OPM %, as of Jun 2025, the value is 59.00%. The value appears to be declining and may need further review. It has decreased from 62.00% (Mar 2025) to 59.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 31.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 135.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.00 Cr. (Mar 2025) to 135.00 Cr., marking a decrease of 11.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 101.00 Cr.. The value appears to be declining and may need further review. It has decreased from 109.00 Cr. (Mar 2025) to 101.00 Cr., marking a decrease of 8.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.08. The value appears to be declining and may need further review. It has decreased from 2.26 (Mar 2025) to 2.08, marking a decrease of 0.18.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:16 am

Growth

Last Updated: September 5, 2025, 5:40 am

Balance Sheet

Last Updated: November 9, 2025, 2:08 pm

Below is a detailed analysis of the balance sheet data for Gujarat Pipavav Port Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 483.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 483.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,691.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,635.00 Cr. (Mar 2025) to 1,691.00 Cr., marking an increase of 56.00 Cr..
• For Borrowings, as of Sep 2025, the value is 51.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 63.00 Cr. (Mar 2025) to 51.00 Cr., marking a decrease of 12.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 475.00 Cr.. The value appears to be improving (decreasing). It has decreased from 498.00 Cr. (Mar 2025) to 475.00 Cr., marking a decrease of 23.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,699.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,681.00 Cr. (Mar 2025) to 2,699.00 Cr., marking an increase of 18.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 1,342.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,329.00 Cr. (Mar 2025) to 1,342.00 Cr., marking an increase of 13.00 Cr..
• For CWIP, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 83.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 57.00 Cr..
• For Investments, as of Sep 2025, the value is 83.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 83.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,248.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,186.00 Cr. (Mar 2025) to 1,248.00 Cr., marking an increase of 62.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,699.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,681.00 Cr. (Mar 2025) to 2,699.00 Cr., marking an increase of 18.00 Cr..

Notably, the Reserves (1,691.00 Cr.) exceed the Borrowings (51.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Gujarat Pipavav Port Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has increased from 7.07 (Mar 24) to 8.21, marking an increase of 1.14.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has increased from 7.07 (Mar 24) to 8.21, marking an increase of 1.14.
• For Cash EPS (Rs.), as of Mar 25, the value is 10.29. This value is within the healthy range. It has increased from 9.27 (Mar 24) to 10.29, marking an increase of 1.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.34. It has increased from 47.85 (Mar 24) to 48.34, marking an increase of 0.49.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 48.34. It has increased from 47.85 (Mar 24) to 48.34, marking an increase of 0.49.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 20.43. It has decreased from 20.45 (Mar 24) to 20.43, marking a decrease of 0.02.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.62. This value is within the healthy range. It has increased from 13.40 (Mar 24) to 13.62, marking an increase of 0.22.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.20. This value is within the healthy range. It has increased from 11.01 (Mar 24) to 11.20, marking an increase of 0.19.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.08. This value is within the healthy range. It has increased from 9.72 (Mar 24) to 11.08, marking an increase of 1.36.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.86. This value is within the healthy range. It has increased from 6.88 (Mar 24) to 7.86, marking an increase of 0.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has increased from 7.07 (Mar 24) to 8.21, marking an increase of 1.14.
• For PBDIT Margin (%), as of Mar 25, the value is 66.68. This value is within the healthy range. It has increased from 65.55 (Mar 24) to 66.68, marking an increase of 1.13.
• For PBIT Margin (%), as of Mar 25, the value is 54.83. This value exceeds the healthy maximum of 20. It has increased from 53.85 (Mar 24) to 54.83, marking an increase of 0.98.
• For PBT Margin (%), as of Mar 25, the value is 54.23. This value is within the healthy range. It has increased from 47.55 (Mar 24) to 54.23, marking an increase of 6.68.
• For Net Profit Margin (%), as of Mar 25, the value is 38.49. This value exceeds the healthy maximum of 10. It has increased from 33.64 (Mar 24) to 38.49, marking an increase of 4.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 40.18. This value exceeds the healthy maximum of 20. It has increased from 34.60 (Mar 24) to 40.18, marking an increase of 5.58.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.98. This value is within the healthy range. It has increased from 14.78 (Mar 24) to 16.98, marking an increase of 2.20.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.99. This value is within the healthy range. It has increased from 20.75 (Mar 24) to 20.99, marking an increase of 0.24.
• For Return On Assets (%), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 11.64 (Mar 24) to 13.52, marking an increase of 1.88.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.34 (Mar 24) to 0.33, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 3.20. This value exceeds the healthy maximum of 3. It has increased from 3.04 (Mar 24) to 3.20, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 2. It has increased from 3.02 (Mar 24) to 3.17, marking an increase of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 104.62. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 104.62, marking an increase of 104.62.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 93.79. This value exceeds the healthy maximum of 50. It has decreased from 98.94 (Mar 24) to 93.79, marking a decrease of 5.15.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 72.42. This value exceeds the healthy maximum of 50. It has decreased from 73.95 (Mar 24) to 72.42, marking a decrease of 1.53.
• For Earning Retention Ratio (%), as of Mar 25, the value is 6.21. This value is below the healthy minimum of 40. It has increased from 1.06 (Mar 24) to 6.21, marking an increase of 5.15.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 27.58. This value is below the healthy minimum of 40. It has increased from 26.05 (Mar 24) to 27.58, marking an increase of 1.53.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 112.20. This value is within the healthy range. It has increased from 69.52 (Mar 24) to 112.20, marking an increase of 42.68.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 65.77. This value is within the healthy range. It has increased from 42.37 (Mar 24) to 65.77, marking an increase of 23.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,604.96. It has decreased from 9,230.95 (Mar 24) to 5,604.96, marking a decrease of 3,625.99.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.67. This value exceeds the healthy maximum of 3. It has decreased from 9.34 (Mar 24) to 5.67, marking a decrease of 3.67.
• For EV / EBITDA (X), as of Mar 25, the value is 8.51. This value is within the healthy range. It has decreased from 14.25 (Mar 24) to 8.51, marking a decrease of 5.74.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 3. It has decreased from 10.40 (Mar 24) to 6.76, marking a decrease of 3.64.
• For Retention Ratios (%), as of Mar 25, the value is 6.20. This value is below the healthy minimum of 30. It has increased from 1.05 (Mar 24) to 6.20, marking an increase of 5.15.
• For Price / BV (X), as of Mar 25, the value is 2.86. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 2.86, marking a decrease of 1.58.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.76. This value exceeds the healthy maximum of 3. It has decreased from 10.40 (Mar 24) to 6.76, marking a decrease of 3.64.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness